Antonio R. Pera's Insider Trades & SAST Disclosures

Antonio R. Pera's most recent trade in ANI Pharmaceuticals Inc was a trade of 7,292 Common Stock done at an average price of $94.9 . Disclosure was reported to the exchange on Sept. 3, 2025.

Share

Note

This is a custom search result for pattern Antonio R. Pera.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Sale of securities on an exchange or to another person at price $ 94.94 per share.	03 Sep 2025	7,292	22,660 (0%)	0%	94.9	692,302	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Sale of securities on an exchange or to another person at price $ 89.73 per share.	20 Aug 2025	5,421	29,952 (0%)	0%	89.7	486,426	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2025	4,336	35,373 (0%)	0%		0	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	4,410	31,037 (0%)	0%		0	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Sale of securities on an exchange or to another person at price $ 65.20 per share.	04 Mar 2024	7,000	26,627 (0%)	0%	65.2	456,400	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Sale of securities on an exchange or to another person at price $ 60.37 per share.	14 Aug 2023	3,000	33,627 (0%)	0%	60.4	181,110	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	6,865	36,627 (0%)	0%		0	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Apr 2022	10,049	29,762 (0%)	0%		0	Common Stock
ANI Pharma Inc FDA Approval	Antonio R. Pera	Director	Purchase of securities on an exchange or from another person at price $ 42.26 per share.	07 Dec 2021	3,000	19,713 (0%)	0%	42.3	126,794	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades